# OnCo record dnatrix (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dnatrix/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dnatrix" ;
  schema:name "DNAtrix"@en ;
  schema:alternateName "DNAtrix, Inc."@en ;
  schema:description "DNAtrix developed viruses, based on a common cold virus, that are engineered to infect and kill cancer cells. Its main candidate, DNX-2401, was tested in brain tumours including glioblastoma and a childhood brainstem tumour. The company has announced nothing since 2021 and its website no longer works."@en ;
  schema:url <https://onco.cc/companies/dnatrix/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/dnatrix-announces-first-patient-dosed-in-clinical-study-of-dnx-2440-an-ox40-ligand-expressing-immunotherapy-in-colorectal-cancer-and-other-cancers-with-liver-metastasis>, <https://clinicaltrials.gov/study/NCT00805376>, <https://clinicaltrials.gov/study/NCT04714983>, <https://clinicaltrials.gov/study/NCT03896568>, <https://clinicaltrials.gov/study/NCT03178032> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .